Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy

NCT07098481 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

576

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis C Virus Infection

Interventions

DRUG: ACCESS+ strategy Epclusa 400/100 Oral Tablet
DRUG: ACCESS+ Strategy Vosevi 400/100/100 Oral Tablet
DRUG: Standard Strategy Vosevi 400/100/100 Oral Tablet
DRUG: Standard Strategy Epclusa 400/100 Oral Tablet

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]